Feb 23, 2017 09:27 PM IST
Data reliability or data integrity are often linked to allegations of data falsification or manipulation, which are cited as main reasons by US FDA for pulling up Indian companies as part of its regulatory scrutiny.
- Feb 23, 2017 01:39 PM IST
Easing regulatory concerns and actions by the US Food and Drug Administration (FDA) will help the sector and improve investor sentiment, Deutsche Bank said in a report.
- Feb 20, 2017 01:28 PM IST
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- Havells, Lloyd Electricals, Idea Cellular, Jaiprakash Power, TCS, JSPL, Torrent Pharma, Amtek Auto, IDBI Bank and Mahanagar Gas.
- Feb 15, 2017 09:32 AM IST
Sudarshan Sukhani of s2analytics.com suggests buying Bharat Heavy Electricals and Indraprastha Gas and advises selling Amara Raja Batteries and Torrent Pharma.
- Feb 14, 2017 01:21 PM IST
Gaurav Bissa of LKP Securities is of the view that one may buy Torrent Pharma, Tech Mahindra and Mahindra & Mahindra while on ecan sell Asian Paints.
- Feb 09, 2017 11:01 AM IST
HDFC Securities is bullish on Torrent Pharma has recommended buy rating on the stock with a target price of Rs 1730 in its research report dated February 06, 2017.
- Feb 08, 2017 05:14 PM IST
Edelweiss is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1625 in its research report dated February 03, 2017.
- Feb 08, 2017 04:06 PM IST
Religare recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 1535 in its research report dated February 03, 2017.
- Feb 08, 2017 01:39 PM IST
Motilal Oswal is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1700 in its research report dated February 03, 2017.
- Feb 07, 2017 03:23 PM IST
ICICI Direct is bullish on Torrent Pharma has recommended buy rating on the stock with a target price of Rs 1475 in its research report dated February 06, 2017.
- Feb 03, 2017 06:22 PM IST
Drug firm Torrent Pharmaceuticals
today reported a consolidated net profit of Rs 229 crore for
the third quarter ended December 31, 2016.
- Feb 03, 2017 08:00 AM IST
BSE | Tata Motors | Surya Roshni | Ujjivan Financial | Tata Power | Excel Crop | Cosmo Films | Subros | Glenmark Pharma | Godfrey Phillips | Aegis Logistics and AstraZeneca are stocks, which are in the news today.
- Jan 17, 2017 04:00 PM IST
Net Sales are expected to increase by 3 percent Q-o-Q (down 4.4 percent Y-o-Y) to Rs 1470 crore, according to HDFC Securities.
- Jan 16, 2017 01:28 PM IST
Net Sales are expected to increase by 5.5 percent Q-o-Q (down 2.1 percent Y-o-Y) to Rs 1507 crore, according to ICICI Securities.
- Jan 14, 2017 02:00 PM IST
Analysts predict Q3 to be a tough quarter with revenue growth moderating to 11.7 percent in October-December period compared to 18.4 percent compounded annual growth rate (CAGR) over last 10 years
- Jan 13, 2017 09:00 AM IST
JP Morgan stays neutral on TCS with target of Rs 2450 per share as company has shown weakness in revenue growth trajectory in recent quarters.
- Jan 09, 2017 04:26 PM IST
Sudip Bandopadhyay, Market Expert is of the view that one can buy MOIL and NMDC even at current level.
- Jan 09, 2017 03:35 PM IST
Hyderabad-based drug maker Granules India took a hit on the bourses on Monday on Portuguese drug regulator Infarmed making 11 observations on company‘s Gagillapur facility near Hyderabad. The observations have prompted market observes to advise caution on the stock.
- Jan 06, 2017 08:01 AM IST
Wockhardt | Tech Mahindra | Sagar Cement | Glenmark | Torrent Pharma | Mastek | Piramal Enterprises | GE Power | Indo Borax | Monnet Ispat | Reliance Communications | GM Breweries and Chartered Logistics are stocks, which are in the news today.
- Jan 04, 2017 10:47 AM IST
Ashwani Gujral of ashwanigujral.com is of the view that DCB bank can test Rs 130-135.
- Dec 30, 2016 08:22 AM IST
Nomura is neutral on Lupin and Torrent. It has a buy rating on Dr Reddy‘s and Cadila. It says trailing three-month sales declined sequentially for Torrent, Sun Pharma and Glenmark. Torrent‘s sales were down on account of price erosion in gAbilify. Sun‘s T3M sales declined QoQ due to price erosion and market share loss in gGleevec.
- Dec 26, 2016 04:51 PM IST
Edelweiss is bullish on Torrent Pharma has recommended buy rating on the stock with a target price of Rs 1665 in its research report dated December 20, 2016.
- Dec 13, 2016 02:52 PM IST
Sandeep Wagle of powermywealth.com recommends buying Mindtree and Bharat Forge and advises selling Torrent Pharma.
- Nov 30, 2016 11:30 AM IST
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Ceat and Torrent Pharma and sell BPCL.
- Nov 30, 2016 11:16 AM IST
Torrent Pharmaceuticals shares surged 4.4 percent intraday Wednesday after approval from the US health regulator for antihypertensive drug and CLSA upgraded to buy.